top of page

Estrogen-Based Therapies As A Potential Disease - Modifying Therapy In Multiple Sclerosis

Abiola Adejana
21/11/26

Although current disease-modifying therapies (DMT) can reduce inflammation and relapses in cases of Multiple Sclerosis (MS), they do not fully prevent neurodegeneration. MS typically impacts women more than men, and disease activity changes according to hormonal fluctuations in the body. Consequently, estrogen has emerged as a potential therapy. These therapies have been tested by combining traditional disease-modifying therapies with them. The effectiveness of this is possible in monoclonal antibodies, and oral drugs. Which could be treatment strategies for MS patients. Estrogen helps the body with neuroprotection, and immunomodularity. Significant amounts of estrogen stimulate myelin repair, protect axons from degeneration, and suppress inflammatory T-cells. This review examines whether estrogen-based therapies could effectively treat MS. Research suggests that estrogen can reduce inflammatory immune activity, and support remyelination. The decrease in relapse rates during pregnancy and the increase postpartum further support a correlation between estrogen and MS activity. Overall, estrogen-based therapies show potential as effective disease-modifying therapies for MS.

bottom of page